General News | Mar. 25, 2015

People With Lupus Must Have Access to Prescription Drugs

People with lupus need and deserve a full arsenal of treatments. With many new and innovative drugs for lupus in the drug pipeline, these highly anticipated treatments will mean nothing if people with lupus cannot afford them.

Research News | Mar. 17, 2015

Preliminary Results Showcase Success of New Lupus Foundation of America Initiative

LFA-REAL aims to improve health and quality of life for people with lupus.

Blog | Mar. 17, 2015

Let’s Play Together and Raise Money for Lupus Foundation of America

Earlier this month, the Lupus Foundation of America was honored to play a role in the launch of Geek & Sundry’s Twitch.tv channel. Read more about the event that raised more than $160,000 for lupus research and awareness programs and how you can host your own fundraiser.

Blog | Mar. 16, 2015

Chris and Dawn Joyner: Siblings Bound by Music

Chris Joyner always looked up to his sister Dawn. Their shared love of music helped Chris become a professional musician but her life with lupus inspired him to write a song about her struggles. Read more.

Research News | Mar. 16, 2015

Foundation-Funded Study Identifies Lupus Related Gene that Affects Adult Stem Cells

A new research study by Foundation grantee Dr. Laurence Morel identifies a lupus related gene that affects adult mesenchymal stem cells. Read more.

Magazine | Mar. 16, 2015

Just Dance

Have fun, get moving, and improve balance through dancing.

Research News | Mar. 13, 2015

Corticosteroid Use and Lupus

Part of a new analysis from the ongoing Hopkins Lupus Cohort provides new knowledge that may help physicians make decisions about gradually reducing corticosteroid doses in people with lupus.

Blog | Mar. 03, 2015

Increasing Federal Support for Lupus Research

This year, the Lupus Foundation of America is implementing numerous projects to achieve our goals to increase federal support for lupus research and services to benefit people with lupus, their families and caregivers. Find out more about two of our exciting endeavors in this letter from our CEO, Sandra C. Raymond.